1.Improve significantly the uptake of photonics technology by end-user industry, in particular SMEs, enabling a demonstrably more competitive European industry.
•Engage new business by providing low-barrier access to low-medium production volumes. MedPhab’s use-cases are developed towards new products and external companies have been contacted to establish joint R&D.
•Provide single entry point to access a complete service, covering all stages of the manufacturing process through front office.
•Simplify an access to advanced photonics technologies through modular approach. In WP3 “production kits” have been defined as a tool to make compatible fabrication chains.
•Lower risk of the decision for companies to enter the market with advanced photonics technologies enabled products to allow the businesses explore different manufacturing options.
•Demonstrate increased industrial leadership through introduction of 5 innovative products by MedPhab Use-Case partners.
•Strengthen European manufacturing capacity by empowering manufacturers with ISO13485 certificate.
2.Greatly accelerate the time to market
• Accelerate the manufacturing process through a holistic approach. This is addressed by the maturity map with technology and manufacture readiness levels to identify the expectations for the joint R&D.
• Pre-qualify for seamless regulatory approval process
MedPhab can provide seamless transition from non-regulated to regulated fabrication thanks to aligned quality standards and understanding on the regulations.
• Optimize customer handling processes
Streamlined customer handling processes have been developed allowing efficient communication with the customer and selection of right MedPhab service providers. All the partners have been trained to provide the same customer experience.
3.Create sustainable manufacturing capability in Europe
• MedPhab non-profit association (NPA) with an executive director was establish to manage the pilot line operations and to act as a front office.
Catalyze open-access ecosystem
• Catalyze open-access ecosystem
MedPhab non-profit association with open-access operational basis was established to manage the pilot line operations and to act as a front office. Relying on MedPhab pilot, Chips-JU pilot line project PhotonMed with 39 partners and 32M€ budget was initiated in September 2024.
https://cordis.europa.eu/project/id/101139777• Leverage regional/national investments
MedPhab, among other pilot lines, are strategically central initiatives for the parties and therefore exploitation and synergies with national investments.
• Form strategic alliances along RTO-industry value chains between MedPhab parties aligning fabrication processes with different maturity levels. Also, the open call rounds have led to over 40 enquiries with the likelihood to lead new long-term alliances. 15 projects with the external partners were implemented.
• Demonstrate ambitious but commercially viable sustainable business plan
The operation of MedPhab non-profit association lies on the sustainable business plan. NPA manages the operation of the pilot line while the renewal of technology offering and invitation of new members take place in ChipsJU-PhotonMed project.
